Xiao Chang

Chinese PLA General Hospital

Papers

1

Total Citations

4

H-Index

1

About

Xiao Chang is a urological researcher whose work focuses on improving surgical outcomes for patients undergoing radical cystectomy and intestinal urinary diversion. In a key 2020 study, Chang introduced the A/G index—a novel biomarker derived from routine blood tests—designed to predict early postoperative complications in this high-risk patient population. This contribution offers clinicians a simple, accessible tool for risk stratification, potentially reducing morbidity and enhancing recovery pathways. While still early in their career, with the A/G index paper accumulating 4 citations, Chang’s work represents a practical step toward personalized surgical care. By bridging the gap between laboratory markers and clinical decision-making, Chang’s research underscores the importance of identifying cost-effective, non-invasive predictors in urologic oncology. Their focus on complication prevention and patient safety highlights a commitment to translating data into actionable insights, making their work relevant for surgeons and researchers seeking to optimize outcomes in complex urological procedures.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
A new index (A/G) associated with early complications of radical cystectomy and intestinal urinary diversion
4 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Chinese PLA General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago